Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction

FASEB Journal

Volumn 14, Issue 5, 2000, Pages 791-796

  Wilson, Michael H ^a   Grant, Peter J ^a   Hardie, Laura J ^a   Wild, Christopher Paul ^a  

^a NONE

Author keywords

Acute myocardial infarction; Case control study; Epoxide hydrolase; GSTM1; RFLP

Indexed keywords

GLUTATHIONE TRANSFERASE; TOBACCO SMOKE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING;

NICOTIANA TABACUM;

EID: 0034081052     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.14.5.791     Document Type: Article

References (31)

1. IARC. (1994) DNA Adducts: Identification and Biological Significance (Hemminki, K., Dipple, A., Shuker. D. E. G., Kadlubar, F. F., Segerback, D., and Bartsch, H., eds) IARC Scientific Publications No 125
2. Denissenko, M. F., Pao, A., Tang, M., and Pfeiler, G. P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 274, 430-432
3. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878
4. Bridges, B. A., Bowyer, D. E., Hansen, E. S., Penn, A., and Wakabayashi, K. (1990) The possible involvement of somatic mutations in the development of atherosclerotic plaques. Report of ICPEMC Subcommittee 7/1 Conclusions and recommendations. Mutat. Res. 239, 143-148
5. Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (London) 362, 801-809
6. De Flora, S., Izzotti, A., Walsh, D., Degan, P., Petrilli, G. L., and Lewtas, J. (1997) Molecular epidemiology of atherosclerosis. FASEB J. 11, 1021-1031
7. Penn, A., and Snyder, C. (1988) Arteriosclerotic plaque development is 'promoted' by polynuclear aromatic hydrocarbons. Carcinogenesis 9, 2185-2189
8. Penn, A., and Snyder, C. A. (1996) 1,3 Butadiene, a vapor phase component of environmental tobacco smoke, accelerates arteriosclerotic plaque. Circulation 93, 552-557
9. Izzotti, A., De Flora, S., Petrilli, G. L., Gallagher, J., Rojas, M., Alexandrov, K., Bartsch, H., and Lewtas, J. (1995) Cancer biomarkers in human atherosclerotic lesions: detection of DNA adducts. Cancer Epidemiol. Biol. Prev. 4, 105-110
10. Izzotti, A., Balansky, R. M., Coscia, N., Scatolini, L., D'Agostini, F., and De Flora, S. (1992) Chemoprevention of smoke-related DNA adduct formation in rat lung and heart. Carcinogenesis 13, 2187-2190
11. van Schooten, F.J., Hirvonen, A., Maas, L. M., De Mol, B. A., Kleinjans, J. C., Bell, D. A., and Durrer, J. D. (1998) Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue. FASEB J. 12, 1409-1417
12. Collins, A. R., Gedik, C. M., Olmedilla, B., Southon, S., and Bellizzi, M. (1998) Oxidative DNA damage measured in human lymphocytes: large differences between sexes and between countries, and correlations with heart disease mortality rates. FASEB J. 12, 1397-1400
13. Taningher, M., Malacarne, D., Izzotti, A., Ugolini, D., and Parodi, S. (1999) Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat. Res. 436, 227-261
14. Harries, L. W., Stubbins, M. J., Forman, D., Howard, G. C., and Wolf, C. R. (1997) Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18, 641-644
15. Hassett, C., Aicher, L., Sidhu, J. S., and Omiecinski, C. J. (1994) Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet. 3, 421-428
16. Kohler, H. P., Stickland, M. H., Ossei-Gerning, N., Carter, A., Mikkola, H., and Grant, P. J. (1998) Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb. Haemost. 79, 8-13
17. Mansfield, M. W., Stickland, M. H., Carter, A., and Grant, P. J. (1994) Polymorphisms of the plasminogen activator inhibitor-1 gene in type 1 and type 2 diabetes and in patients with diabetic retinopathy. Thromb. Haemost. 71, 731-736
18. Abdel-Rahman, S. Z., el-Zein, R. A., Anwar, W. A., and Au, W. W. (1996) A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett. 107, 229-233
19. Smith, C. A., and Harrison, D. J. (1997) Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350, 630-633
20. Pessah-Rasmussen, H., Seidegard, J., Stavenow, L., Solem, J. O., Lindblad, B., and Xu, C. B. (1993) Glutathione transferase activity in human vessels and in cultured arterial smooth muscle cells, Int. Angiol. 12, 348-354
21. Lapenna, D., de Gioia, S., Ciofani, G., Mezzetti, A., Ucchino, S., Calafiore, A. M., Napolitano, A. M., Di Ilio, C., and Cuccurullo, F. (1998) Glutathione-related antioxidant defenses in human atherosclerotic plaques. Circulation 97, 1930-1934
22. Rosenberg, L., Kaufman, D. W., Helmrich, S. P., and Shapiro, S. (1985) The risk of myocardial infarction after quitting smoking in men under 55 years of age. N. Engl. J. Med. 313, 1511-1514
23. Hayes, J. D., and Pulford, D. J. (1995) The glutathione S-transferase supergene family, regulation of GST* and the contribution of the enzyme to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 30, 445-600
24. Kihara, M., and Noda, K. (1994) Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis 15, 415-418
25. McWilliams, J. E., Sanderson, B. J., Harris, E. L., Richert-Boe, K. E., and Henner, W. D. (1995) Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol. Biol., Prev. 4, 589-594
26. Kato, S., Bowman, E. D., Harrington, A. M., Blomeke, B., and Shields, P. G. (1995) Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J. Natl. Cancer Inst. 87, 902-907
27. Ryberg, D., Skaug, V., Hewer, A., Phillips, D. H., Harries, L. W., Wolf, C. R., Ogreid, D., Ulvik, A., Vu, P., and Haugen, A. (1997) Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 18, 1285-1289
28. Pessah-Rasmussen, H., Jerntorp, P., Stavenow, L., Elmstahl, S., Hansen, F., Seidegard, J., Galvard, H., Brattstrom, L., and Hamfelt, A. (1990) Eighty-year-old men without cardiovascular disease in the community of Malmo. Part II. Smoking characteristics and ultrasound findings, with special reference to glutathione transferase and pyridoxal-5-phosphate. J. Int. Med. 228, 17-22
29. Pickett, C. B., and Lu, A. Y. H. (1989) Glutathione S-transferases - gene structure, regulation, and biological function. Annu. Rev. Biochem. 58, 743-764
30. Anttila, S., Luostarinen, L., Hirvonen, A., Elovaara. E., Karjalainen, A., Nurminen, T., Hayes, J. D., Vainio, H., and Ketterer, B. (1995) Pulmonary expression of glutathione S-transferase M3 in lung cancer patients: association with GSTM1 polymorphism, smoking, and asbestos exposure. Cancer Res. 55, 3305-3309
31. MacLeod, S., Sinha, R., Kadlubar, F. F., and Lang, N. (1997) Polymorphisms of CYP1a1 and GSTM1 influence the in vivo function of CYP1A2. Mutat. Res. 376, 135-142